Panacea Biotec Ltd.
| BSE: 531349 | Sector: Health care |
| NSE: PANACEABIO | ISIN Code: INE922B01023 |
| BSE 00:00 | 13 Aug | 197.95 |
0.90 (0.46%) |
OPEN
200.00 |
HIGH
201.90 |
LOW
197.05 |
| NSE 00:00 | 13 Aug | 197.80 |
0.85 (0.43%) |
OPEN
198.55 |
HIGH
201.85 |
LOW
197.05 |
| OPEN | 200.00 |
| PREVIOUS CLOSE | 197.05 |
| VOLUME | 17045 |
| 52-Week high | 263.00 |
| 52-Week low | 90.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 1,213 |
| Buy Price | 197.95 |
| Buy Qty | 1.00 |
| Sell Price | 198.90 |
| Sell Qty | 200.00 |
Panacea Biotec Ltd. (PANACEABIO) - Share Holding
| (in %) | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 |
| Promoter & Group | |||||
| Foreign | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Indian | 73.59 | 73.59 | 73.59 | 73.59 | 73.59 |
| Total Promoters | 73.59 | 73.59 | 73.59 | 73.59 | 73.59 |
| Non Promoter | |||||
| Institutions | 1.28 | 1.61 | 1.76 | 1.80 | 1.93 |
| Financial Institutions / Banks | 0.00 | 0.01 | 0.02 | 0.01 | 0.07 |
| Foreign Institutional Investors | 0.00 | 0.00 | 0.14 | 0.19 | 0.28 |
| Insurance Companies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mutual Funds / UTI | 1.28 | 1.60 | 1.59 | 1.59 | 1.59 |
| Non-Institution | 25.13 | 24.79 | 24.65 | 24.61 | 24.48 |
| Indian Public | 13.31 | 11.87 | 12.20 | 12.11 | 11.96 |
| Others | 11.82 | 12.92 | 12.45 | 12.50 | 12.52 |
| Total Non Promoter | 26.41 | 26.40 | 26.41 | 26.41 | 26.41 |
| Total Promoter & Non Promoter | 100.00 | 99.99 | 100.00 | 100.00 | 100.00 |
| Custodians | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Grand Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Quick Links for Panacea Biotec:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
